Gland Pharma Ltd vs Shilpa Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Gland Pharma Ltd is ₹ 2261 as of 12 Jun 15:30 . The P/E Ratio of Gland Pharma Ltd changed from 40.7 on March 2021 to 37.5 on March 2025 . This represents a CAGR of -1.62% over 5 yearsThe P/E Ratio of Shilpa Medicare Ltd changed from 18.4 on March 2021 to 82.8 on March 2025 . This represents a CAGR of 35.10% over 5 years The Market Cap of Gland Pharma Ltd changed from ₹ 40535 crore on March 2021 to ₹ 26232 crore on March 2025 . This represents a CAGR of -8.34% over 5 yearsThe Market Cap of Shilpa Medicare Ltd changed from ₹ 2721 crore on March 2021 to ₹ 6483 crore on March 2025 . This represents a CAGR of 18.96% over 5 years The revenue of Gland Pharma Ltd for the Mar '26 is ₹ 1854 crore as compare to the Dec '25 revenue of ₹ 1758 crore. This represent the growth of 5.44% The revenue of Shilpa Medicare Ltd for the Mar '26 is ₹ 482 crore as compare to the Dec '25 revenue of ₹ 410.54 crore. This represent the growth of 17.41% The ebitda of Gland Pharma Ltd for the Mar '26 is ₹ 624.49 crore as compare to the Dec '25 ebitda of ₹ 473.7 crore. This represent the growth of 31.83% The ebitda of Shilpa Medicare Ltd for the Mar '26 is ₹ 164.72 crore as compare to the Dec '25 ebitda of ₹ 101.89 crore. This represent the growth of 61.66% The net profit of Gland Pharma Ltd changed from ₹ 143.76 crore to ₹ 366.68 crore over 8 quarters. This represents a CAGR of 59.71% The net profit of Shilpa Medicare Ltd changed from ₹ 14.06 crore to ₹ 107.79 crore over 8 quarters. This represents a CAGR of 176.88% The Dividend Payout of Gland Pharma Ltd changed from 31.57 % on March 2024 to 27.22 % on March 2025 . This represents a CAGR of -7.14% over 2 yearsThe Dividend Payout of Shilpa Medicare Ltd changed from 4.86 % on March 2021 to 14.01 % on March 2025 . This represents a CAGR of 23.58% over 5 years .

About Gland Pharma Ltd

Gland Pharma Limited was incorporated as Gland Pharma Private Limited', a private limited company on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
Subsequently, the name of the Company was changed to Gland Pharma Limited' and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
The Company is primarily engaged in manufacturing injectable formulations. Established in Hyderabad, India, Company has evolved into a prominent entity in the global generic injectables market, with operations extending to over 60 countries including the United States, Europe, Canada, Australia, and India.
Primarily functioning under a B2B model, the company provides comprehensive services such as contract development, dossier compilation, technology transfer, and manufacturing across various delivery systems.

About Shilpa Medicare Ltd

Shilpa Medicare Limited, formerly known as Shilpa Antibiotics Private Limited was incorporated as a Private Company on November 20, 1987.
The Company changed the status to Public and the name of the Company changed to Shilpa Antibiotics Limited in November, 1993 and later on, was changed to 'Shilpa Medicare Limited' on February 17, 2003. The Company has been promoted by Vishnukant C. Bhutada and his Associates and is engaged in manufacturing of API, Formulation and Development service.
The Company started its operations as API manufacturer way back in 1987 at Raichur, Karnataka.
It then started commercial production in November, 1989. The Company is one of the leading API and formulations manufacturers with strong capabilities in the therapeutic area of oncology.
It supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various regulated markets including USA, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets.

FAQs for the comparison of Gland Pharma Ltd and Shilpa Medicare Ltd

Which company has a larger market capitalization, Gland Pharma Ltd or Shilpa Medicare Ltd?

Market cap of Gland Pharma Ltd is 37,299 Cr while Market cap of Shilpa Medicare Ltd is 10,682 Cr

What are the key factors driving the stock performance of Gland Pharma Ltd and Shilpa Medicare Ltd?

The stock performance of Gland Pharma Ltd and Shilpa Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gland Pharma Ltd and Shilpa Medicare Ltd?

As of June 14, 2026, the Gland Pharma Ltd stock price is INR ₹2261.1. On the other hand, Shilpa Medicare Ltd stock price is INR ₹546.2.

How do dividend payouts of Gland Pharma Ltd and Shilpa Medicare Ltd compare?

To compare the dividend payouts of Gland Pharma Ltd and Shilpa Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.